Form 8-K - Current report:
SEC Accession No. 0001683168-21-003217
Filing Date
2021-08-02
Accepted
2021-08-02 16:05:19
Documents
1
Period of Report
2021-07-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K sonoma_8k.htm 8-K 15206
  Complete submission text file 0001683168-21-003217.txt   16470
Mailing Address 645 MOLLY LANE, SUITE 150 WOODSTOCK GA 30189
Business Address 645 MOLLY LANE, SUITE 150 WOODSTOCK GA 30189 800-759-9305
Sonoma Pharmaceuticals, Inc. (Filer) CIK: 0001367083 (see all company filings)

EIN.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-33216 | Film No.: 211136020
SIC: 2834 Pharmaceutical Preparations